A comprehensive meta-analysis of procrastination research, 10 years in the making, shows that: Most people’s New Year’s resolutions are doomed to failure; self-help books have it wrong when they say perfectionism is the root cause of procrastination, and procrastination can be explained by a single mathematical equation.
Using a new and dramatically effective treatment approach, scientists at the Scripps Research Institute have for the first time achieved complete inhibition of new blood vessel growth in animal models of a highly vascular brain tumor and of neovascular eye diseases with little or no effect on normal tissue vasculature.
By all expectations, it shouldn’t have worked as well as it did. A combination of bone marrow transplantation and gene therapy greatly lengthened the lives of laboratory mice doomed by a rapidly progressing, fatal neurodegenerative disorder also found in people.
Little research exists demonstrating that testosterone is both safe from the cardiovascular standpoint and effective to treat sexual dysfunction, reveal Mayo Clinic researchers in two new studies.
Answering one of the oldest questions in human physiology, researchers at Dana-Farber Cancer Institute have discovered why the body’s immune system — perpetually on guard against foreign microbes like bacteria — doesn’t attack tissues in the small intestine that harbor millions of bacteria cells.
A research team at Wake Forest University Baptist Medical Center and the University of Heidelberg has proven that a gene protects some people with diabetes from developing severe kidney failure or “end-stage renal disease.”
A blood test for patients with coronary heart disease could help predict their risk for subsequent cardiovascular events or death, according to a study in the Jan_10 issue of JAMA.
The Department of Health (DH) today (January 9) urged members of the public not to buy or use a proprietary Chinese medicine called Boy Joy, which was found to contain potentially hazardous ingredients that may cause side effects.
Thai researchers have discovered that patients who fail treatment with a commonly used, inexpensive, first-line antiretroviral therapy (ART) are also usually resistant to other, similar drugs, leaving progressively fewer options for replacement therapies. Since catching treatment failure early is key to preventing further resistance, this research, published in the February 1 issue of Clinical Infectious Diseases also argues for greater access in the developing world to tests that detect when the amount of virus in a patient’s blood is increasing.
A preliminary study suggests there may be hope in the offing for some sufferers of chronic fatigue syndrome with a new therapy being tested by researchers at the Stanford University School of Medicine.